Transparency
Market Research Report Added “Circulating
Tumor Cells (CTCs) Prognostic Technologies Market"
to its database.
Circulating
Tumor Cells (CTCs) Prognostic Technologies Market: Description
This
report provides the market analysis for various technologies and
applications used for the enrichment and detection of circulating
tumor cells (CTCs). The stakeholders of this report include companies
and research institutes involved in the production of prognosis kits
and research and development activities related to circulating tumor
cells technologies as well as the new entrants who wish to enter this
market.
The
market overview section of the report analyzes the market dynamics
and trends such as drivers, restraints and opportunities that would
affect the current and future scenario of the CTC technologies
market. Porter’s five forces analysis is included in this study to
provide thorough analysis about the competitive status, and market
attractiveness analysis has been added to describe the market outlook
in different geographies. Event impact analysis is provided in this
report for a brief understanding of the technological advancements
that have taken place in the past and are planned for the future.
Value chain analysis of the market is discussed to recognize
value-creating activities from a number of processes, which can
provide CTC technology a competitive advantage over other
technologies.
Circulating
tumor cells (CTCs) are specialized rare cells detached from primary
tumors and disseminated in the vasculature system of the body,
eventually causing metastasis. CTCs are composed of cells that act as
seeds for successive development of additional metastatic tumors in
essential distant organs, which is a cause of majority of
cancer-related deaths. These CTCs are not easily detected, as these
are present in less numbers in the blood stream. Tumors shed nearly 1
million circulating tumor cells (CTCs) per gram of tumor tissue. The
global circulating tumor cells (CTCs) prognostic technologies market
is segmented based on technologies and applications. Moreover, the
technology market is further segmented into tumor cell enrichment and
tumor cell detection.
Browse
Market Research
Report:
http://www.transparencymarketresearch.com/ctcs-prognostic-technologies-market.html
http://www.transparencymarketresearch.com/ctcs-prognostic-technologies-market.html
Overview
of The Global Circulating
Tumor Cells (CTCs) Prognostic Technologies Market
Circulating
tumor cells (CTCs) are specialized rare cells, which have been shed
from a primary solid tumor of the body and circulate in the
vasculature system of the body, eventually causing metastasis. CTCs
act as the seeds for successive development of additional metastatic
tumors in distant organs, which is liable for the majority of
cancer-related deaths. On the other hand, these fatal rare cells are
capable of providing useful information of cancer patients, since
their monitoring and detection is valuable for predicting the
response to treatment and prognosis as well as staging of the
disease. These rare cells are found both in the bone marrow and in
peripheral blood of the body. However, the CTCs found in the blood
usually have a short survival time as compared to CTCs found in the
bone marrow, which makes the analysis of blood sample for CTCs more
specific, thus known as “liquid biopsy”. Therefore, detection of
CTCs during the progression of the tumor provides a prognostic value
of the tumor progression as well as evaluates the efficacy of
therapeutic intervention and provides necessary information for
developing personalized medicines.
The
primary factors driving the growth of the CTCs prognostic
technologies market are increasing demand for diagnostic and
prognostic technologies coupled with high incidence and prevalence
rates of cancer. Furthermore, colossal application scope of these
technologies and patient safety are also some of the factors driving
the growth of the CTCs prognostic technologies market. Additionally,
substantial cost benefit ratio of these technologies and wide use in
therapeutic monitoring are some of the other significant factors that
are expected to fuel the growth of the CTCs technologies globally.
However, some of the important factors that are restraining the
growth of this market are high pricing associated with the
technologies and stringent regulatory policies.
Fill
the form for an exclusive sample of this report:
The
global circulating tumor cells (CTCs) prognostic technologies market
is segmented as follows:
Circulating
Tumor Cells (CTCs) Prognostic Technologies Market, by Technology
Tumor
Cell Enrichment
Filtration
Centrifugation
Immunological
& Immunomagnetic Methods
Tumor
Cell Detection
Molecular
Methods
Optical
Methods
Circulating
Tumor Cells (CTCs) Prognostic Technologies Market, by Applications
Prostate
Cancer
Breast
Cancer
Colorectal
Cancer
Others
(Lung, Ovarian and Pancreatic Cancer)
No comments:
Post a Comment